A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, follicular lymphoma, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm	Recruiting	Not stated	2026-10-09		NCT07154823

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tempus AI	18

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Avera Cancer Institue	Sioux Falls	United States	1
Cancer Care Associates of York	York	United States	41
Cancer Care Specialists of Reno	Reno	United States	1
Novant Health Weisiger Cancer Institute	Charlotte	United States	1
OhioHealth Research Institute	Columbus	United States	18
Sanford Fargo	Fargo	United States	1
Sanford Sioux Falls	Sioux Falls	United States	1
Taylor Cancer Research Center	Maumee	United States	24
The Center for Cancer and Blood Disorders	Bethesda	United States	7
University of Cincinnati	Cincinnati	United States	55
University of Iowa Hospital and Clinics	Iowa City	United States	30
University of Rochester	Rochester	United States	10
Washington University in St. Louis	St Louis	United States	35